All Stories

  1. Novel three-dimensional biochip pulmonary sarcoidosis model
  2. Presence of concurrent sarcoid-like granulomas indicates better survival in cancer patients: a retrospective cohort study
  3. Impact of seasonal variation in meteorological conditions on dry eye severity
  4. A Young Woman with Bradycardia and Hypotension
  5. Regulatory genes in sarcoidosis
  6. A risky political game with climate change
  7. Improving adherence to alpha-1 antitrypsin deficiency screening guidelines using the pulmonary function laboratory
  8. The roles of miRNAs as potential biomarkers in lung diseases
  9. Management of extrapulmonary sarcoidosis: challenges and solutions
  10. Climate change
  11. The simultaneous recording of right- and left-sided electrocardiogram in acute pulmonary embolism
  12. Haarlem 3 is the predominant genotype family in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in the capital of Iran: A 5-year survey
  13. Annexins family: insights into their functions and potential role in pathogenesis of sarcoidosis
  14. High prevalence of Mycobacterium tuberculosis mixed infection in the capital of moderate tuberculosis incidence country
  15. Incidence and predictors of ischemic cerebrovascular stroke among patients on extracorporeal membrane oxygenation support
  16. In VitroAntimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran
  17. Pulmonary Mycobacterium Simiae infection and HTLV1 infection: an incidental co-infection or a predisposing factor?
  18. Reply: Metabolomics and Mycobacterial Disease: Don’t Forget the Bioinformatics
  19. Microbiological Analysis of Hemodialysis Water in a Developing Country
  20. Duration of ECMO Is an Independent Predictor of Intracranial Hemorrhage Occurring During ECMO Support
  21. The Association between ESR and CRP and Systemic Hypertension in Sarcoidosis
  22. English
  23. Metabolomics: Applications and Promise in Mycobacterial Disease
  24. Gender susceptibility to mycobacterial infections in patients with non-CF bronchiectasis
  25. Recurrent Drug-Induced Hepatitis in Tuberculosis—Comparison of Two Drug Regimens
  26. “Multidrug-resistant tuberculosis” may be nontuberculous mycobacteria
  27. Plasma Free Hemoglobin Is an Independent Predictor of Mortality among Patients on Extracorporeal Membrane Oxygenation Support
  28. Primary sclerosing cholangitis in common variable immune deficiency
  29. Identification and Genotyping of Mycobacterium tuberculosis Isolated From Water and Soil Samples of a Metropolitan City
  30. Association of serum TNF-α, IL-8 and free light chain with HLA-DR B alleles expression in pulmonary and extra-pulmonary sarcoidosis
  31. Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective
  32. Persistence of Mycobacterium tuberculosis in environmental samples
  33. Nontuberculous mycobacterial disease in North America
  34. Nontuberculous mycobacteria in Middle East: Current situation and future challenges
  35. A descriptive analysis of nontuberculous mycobacterial infections (NTM) of the upper extremity
  36. Racial Difference in Sarcoidosis Mortality in the United States
  37. Nontuberculous Mycobacteria: Epidemiologic, Mycobacteriologic, and Clinical Aspects
  38. Nontuberculous Mycobacteria Isolation from Clinical and Environmental Samples in Iran: Twenty Years of Surveillance
  39. Molecular Epidemiology of Nontuberculous Mycobacteria Isolates from Clinical and Environmental Sources of a Metropolitan City
  40. Pneumococcal Vaccine and Patients with Pulmonary Diseases
  41. Pneumococcal Vaccines: Understanding Centers for Disease Control and Prevention Recommendations
  42. The role of vaccination in preventing pneumococcal disease in adults
  43. Nontuberculous Mycobacterial Disease Mortality in the United States, 1999–2010: A Population-Based Comparative Study
  44. Rituximab in the treatment of refractory pulmonary sarcoidosis
  45. Highlight on Advances in Nontuberculous Mycobacterial Disease in North America
  46. Multidrug-resistant tuberculosis treatment with linezolid-containing regimen
  47. Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis
  48. Nonsteroidal therapy of sarcoidosis
  49. Antineutrophil Cytoplasmic Autoantibody–Associated Systemic Vasculitis is Associated With Epstein-Barr Virus in the Setting of HIV Infection
  50. Outcomes in females hospitalised with community-acquired pneumonia are worse than in males
  51. Outcome of Nursing Home Associated Pneumonia in African American Hospitalized Patients
  52. A Comparison of Outcomes of Culture Positive Health-care-Associated and Community-Acquired Pneumonia in African American Population: A Community Hospital Experience
  53. Association Between Time to Clinical Stability and Outcomes After Discharge in Hospitalized Patients With Community-Acquired Pneumonia
  54. Generalized lymphadenopathy with cystic spleen lesions: a rare presentation of tuberculosis
  55. Utility of gastric lavage for diagnosis of tuberculosis in patients who are unable to expectorate sputum
  56. Thrombocytopenia and Thrombocytosis at Time of Hospitalization Predict Mortality in Patients With Community-Acquired Pneumonia
  57. Vitamin D receptor homozygote mutant tt and bb are associated with susceptibility to pulmonary tuberculosis in the Iranian population
  58. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran—eight years of surveillance
  59. The NRAMPI, VDR and TNF-α gene polymorphisms in Iranian tuberculosis patients: the study on host susceptibility
  60. Predicting Mortality in Patients with Ventilator‐Associated Pneumonia: The APACHE II Score versus the New IBMP‐10 Score
  61. Nontuberculous Mycobacteria Among Patients Who are Suspected for Multidrug-Resistant Tuberculosis—Need for Earlier Identification of Nontuberculosis Mycobacteria
  62. Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study
  63. Incidence, Etiology, Timing, and Risk Factors for Clinical Failure in Hospitalized Patients With Community-Acquired Pneumonia
  64. The Recent-Transmission of Mycobacterium tuberculosis Strains among Iranian and Afghan Relapse Cases: a DNA-fingerprinting using RFLP and spoligotyping
  65. Acute Myocardial Infarction in Hospitalized Patients with Community‐Acquired Pneumonia
  66. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran
  67. Do mitochondrial DNA haplogroups play a role in susceptibility to tuberculosis?
  68. Multi-drug Resistant Tuberculosis in Pregnancy: Need for More Intensive Treatment
  69. Differences in characteristics between Afghani and Iranian patients with pulmonary tuberculosis
  70. Prevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients
  71. Chronic Granulomatous Disease with Unusual Clinical Manifestation, Outcome, and Pattern of Inheritance in an Iranian Family
  72. Lack of association between interferon‐gamma receptor‐1 polymorphism and pulmonary TB in Iranian population sample
  73. The most prevalent Mycobacterium tuberculosis superfamilies among Iranian and Afghan TB cases
  74. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran
  75. Inherited disorders of the IL-12-IFN-γ axis in patients with disseminated BCG infection
  76. Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations
  77. Primary multi-drug resistant tuberculosis presented as lymphadenitis in a patient without HIV infection